Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yu. R. Zalyalov"'
Publikováno v:
Онкогематология, Vol 0, Iss 1-2, Pp 27-30 (2022)
Acute graft-versus-host disease (GFHD) and graft rejection reaction (GRR) early in the post-transplantation period are main complications of allogeneic transplantation of hematopoietic stem cells. We analyzed the incidence of principal early complica
Externí odkaz:
https://doaj.org/article/1bc57579823243c19b6d1f186c68f95d
Autor:
A. A. Mamedova, N. E. Mochkin, V. O. Sarzhevskiy, E. A. Demina, V. S. Bogatyrev, A. A. Spornik, A. A. Samoylova, A. A. Rukavitsin, E. G. Smirnova, A. E. Bannikova, V. Ya. Melnichenko, N. B. Mikhaylova, E. S. Borzenkova, L. V. Stelmakh, Yu. R. Zalyalov, A. A. Semenova, G. S. Tumyan, M. A. Danilova, O. A. Konova, N. A. Falaleeva, A. Yu. Terekhova, M. A. Vernyuk, A. M. Chervontseva, L. S. Khayrullina, A. A. Maslov, I. B. Lysenko, Yu. A. Alekseeva, E. S. Pavlyuchenko, A. A. Mirsaitov, A. A. Zverkova, I. V. Ishmatova, S. A. Volchenkov, M. S. Motalkina, I. S. Zyuzgin
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 40-47 (2022)
Aim. To study the efficacy and safety of combined immunochemotherapy according to the DHAp protocol + nivolumab in patients with refractory/relapsed classical Hodgkin's lymphoma before autologous hematopoietic stem cell transplantation.Materials and
Externí odkaz:
https://doaj.org/article/61dd8e7c89fc477eb1ba03f4c408b04b
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 28, Iss 4, Pp 9-21 (2022)
There is an increase in the incidence of multiple sclerosis in the world. Only in half of the cases, standard therapy allows for a short time to achieve control over this disease. High-dose immunosuppressive therapy and autologous hematopoietic stem
Externí odkaz:
https://doaj.org/article/ff5ba8feb25e4072b7b8f18d09a6623f
Autor:
K. V. Lepik, N. V. Mikhailova, E. V. Kondakova, L. A. Tsvetkova, Yu. R. Zalyalov, E. S. Borzenkova, I. S. Moiseev, V. V. Baykov, B. A. Afanasyev
Publikováno v:
Онкогематология, Vol 13, Iss 4, Pp 17-26 (2019)
Background . Using modern first-line chemotherapy more than 80 % of patients with classical Hodgkin’s lymphoma can be cured, however, in 15–20 % of cases there is a relapsed/refractory disease. The use of nivolumab in international clinical pract
Externí odkaz:
https://doaj.org/article/e56b56508ac94cdab15e966db111c694
Autor:
A. Yu. Polushin, Yu. R. Zalyalov, A. N. Gavrilenko, A. A. Tsynchenko, E. I. Lopatina, I. B. Skiba, M. A. Estrina, E. V. Babenko, A. A. Gotovchikov, L. N. Prakhova, A. G. Ilves, N. A. Totolyan, A. D. Kulagin, A .A. Skoromets
Publikováno v:
Russian neurological journal. 27:25-35
Introduction. In 2018–2020, a study was conducted in the Russian Federation on the efficacy and safety of highdose immunosuppressive therapy with autologous hematopoietic stem cell transplantation (HDIT-AHSCT) in multiple sclerosis (MS).The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35a4260ef1dcb55758192e6b5a2bdc44
https://doi.org/10.30629/2658-7947-2022-27-5-25-35
https://doi.org/10.30629/2658-7947-2022-27-5-25-35
Publikováno v:
Терапевтический архив, Vol 82, Iss 8, Pp 53-56 (2010)
Aim. To evaluate the efficacy of antithymocyte globulin (ATG) used in conditioning modes before allogeneic hemopoietic cell transplantation (allo-HCT) and its effect in reducing the incidence of posttransplantation complications. Subjects and methods
Externí odkaz:
https://doaj.org/article/65c3b79d67a74db295560ace8a897273
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 48-52 (2010)
Aim. To evaluate the efficiency of related and unrelated allogeneic bone marrow transplantation (allo-BMT) versus immunosuppressive therapy (IST) in patients with aplastic anemia (AA) having no HLA-compatible bone marrow donor. Subjects and methods.
Externí odkaz:
https://doaj.org/article/b13bcf9bd7214261a3383b62b814b29d